Artal Group’s Akebia Therapeutics AKBA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q3 | – | Sell |
-574,000
| Closed | -$7.8M | – | 124 |
|
|
2020
Q2 | $7.8M | Buy |
574,000
+149,000
| +35% | +$2.02M | 0.22% | 68 |
|
|
2020
Q1 | $3.22M | Hold |
425,000
| – | – | 0.14% | 76 |
|
|
2019
Q4 | $2.69M | Hold |
425,000
| – | – | 0.1% | 77 |
|
|
2019
Q3 | $1.67M | Hold |
425,000
| – | – | 0.07% | 86 |
|
|
2019
Q2 | $2.06M | Sell |
425,000
-50,000
| -11% | -$242K | 0.08% | 81 |
|
|
2019
Q1 | $3.89M | Hold |
475,000
| – | – | 0.16% | 69 |
|
|
2018
Q4 | $2.63M | Hold |
475,000
| – | – | 0.1% | 64 |
|
|
2018
Q3 | $4.19M | Hold |
475,000
| – | – | 0.11% | 58 |
|
|
2018
Q2 | $4.74M | Hold |
475,000
| – | – | 0.1% | 50 |
|
|
2018
Q1 | $4.53M | Buy |
+475,000
| New | +$4.53M | 0.06% | 49 |
|